comprehensive -WSS

comprehensive

author：knowledge 2025-09-28 00:49:42 - browse：69

Photograph of Bill Cassidy. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Kevin Dietsch/Getty Images

WASHINGTON — With Novo Nordisk’s Wegovy and Ozempic hitting blockbuster sales and a new rival approved this week, everyone in Washington is thinking about how to manage the crashing wave of weight loss drug costs.

The explosive national demand for weight management therapies and diabetes drugs like Ozempic — all of which are indicated for indefinite use — has become central in an ongoing policy debate over high drug costs and controversial tactics to manage them, including President Biden’s plan to let the government negotiate directly with pharmaceutical companies. Seventy percent of Americans could qualify for these medicines.

Sen. Bill Cassidy (R-La.), the highest-ranking Republican on the Senate’s health policy committee, has vehemently opposed the negotiation plan, arguing it reduces incentives to develop new therapies and may not actually reduce patients’ costs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： UCSF medical school apologizes for unethical prisoner experiments

WSS

Will General Catalyst be the first of many hospital takeovers?

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Biotech incubator Curie.Bio graduates its first startup

FDA approves potent Eli Lilly obesity drug, Zepbound

How Medicaid coverage policies for immigrants impact new moms

STAT Virtual Event: The State of Biosimilars: What to Watch

entertainment

comprehensive

hotspot

Moonlake's readout produced a cash windfall. Risks remain

UCSF medical school apologizes for unethical prisoner experiments

DIEP, the 'gold standard' of breast reconstruction, is under threat

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Medicare proposal to cover medical devices draws a mixed reaction

Senate panel clears PBM, hopsital reforms

Dobbs anniversary: the lost opportunity of abortion as health care

AI can’t replace a physician’s gut feeling

Peter Hotez and the public health issue of online harassment

The Sacklers, horror, and ‘The Fall of the House of Usher’

explore

Will General Catalyst be the first of many hospital takeovers?

Extreme heat events are a public health emergency

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

UCSF medical school apologizes for unethical prisoner experiments

Removing probiotics from the NICU could threaten preemies' health

FDA approves potent Eli Lilly obesity drug, Zepbound

entertainment

hotspot

Wikipedia

focus